82 related articles for article (PubMed ID: 7431677)
1. Purification of tumor-associated embryonic substance from mouse ascites tumor cells: its cross-reactivity with human CEA.
Saito M; Tanino T; Egawa K
Jpn J Exp Med; 1980 Jun; 50(3):197-204. PubMed ID: 7431677
[TBL] [Abstract][Full Text] [Related]
2. Growth stage-dependent sialylation of tumor-associated embryonic substances on mouse ascites tumor cells.
Saito M; Tanino T; Egawa K
Jpn J Exp Med; 1980 Jun; 50(3):189-96. PubMed ID: 7431676
[TBL] [Abstract][Full Text] [Related]
3. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
Egawa K; Kiyohara T; Tanino T
Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
[TBL] [Abstract][Full Text] [Related]
4. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
5. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
[TBL] [Abstract][Full Text] [Related]
6. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
7. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
[TBL] [Abstract][Full Text] [Related]
8. Purification of cell line-specific transplantation antigens from mouse ascites tumor cells.
Tanino T; Saito M; Egawa K
Gan; 1982 Apr; 73(2):299-307. PubMed ID: 7117755
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
10. Studies on the tumor-host relationship. IV. Tumor cell agglutination with survival mouse serum.
Tanino T; Tsumita T
Jpn J Exp Med; 1972 Aug; 42(4):401-13. PubMed ID: 4341690
[No Abstract] [Full Text] [Related]
11. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
[TBL] [Abstract][Full Text] [Related]
13. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
15. Egg lectin of Rana japonica and its receptor glycoprotein of Ehrlich tumor cells.
Sakakibara F; Kawauchi H; Takayanagi G; Ise H
Cancer Res; 1979 Apr; 39(4):1347-52. PubMed ID: 570454
[TBL] [Abstract][Full Text] [Related]
16. Humoral reactions in syngeneic hosts against tumor cell surface incomplete saccharide moieties.
Tanino T; Egawa K
Int J Cancer; 1976 Jun; 17(6):730-5. PubMed ID: 947853
[TBL] [Abstract][Full Text] [Related]
17. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
[TBL] [Abstract][Full Text] [Related]
18. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
[TBL] [Abstract][Full Text] [Related]
19. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
20. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
Clarke P; Mann J; Simpson JF; Rickard-Dickson K; Primus FJ
Cancer Res; 1998 Apr; 58(7):1469-77. PubMed ID: 9537250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
